Filter
756
Filtered Results: 756
Text search:
good
prescribing
practice
Featured
Recommendations
96
New Publications
191
Language
Document type
No document type
378
Guidelines
152
Studies & Reports
123
Manuals
45
Strategic & Response Plan
24
Training Material
16
Fact sheets
9
Situation Updates
4
Resource Platforms
4
Online Courses
1
Countries / Regions
India
47
South Africa
31
Kenya
28
Global
26
Uganda
20
Western and Central Europe
18
Ethiopia
16
Ghana
15
Tanzania
15
Malawi
10
Namibia
10
Nepal
9
Liberia
9
Sierra Leone
8
Rwanda
7
Nigeria
7
Zimbabwe
7
Latin America and the Carribbean
7
Botswana
7
Lesotho
6
Africa
6
Ukraine
5
Haiti
5
Zambia
5
Eswatini/ Swaziland
5
Cameroon
4
South–East Asia Region
4
Eastern Europe and Central Asia
4
Bangladesh
4
Eastern Europe
4
Myanmar / Burma
4
Jordan
3
Western Pacific Region
3
United Kingdom
3
Indonesia
3
Syria
2
Laos
2
Burkina Faso
2
Philippines
2
USA
2
Germany
2
Vietnam
2
Sri Lanka
2
El Salvador
1
Australia
1
China
1
Chile
1
Fiji
1
Senegal
1
Peru
1
Qatar
1
Mozambique
1
Cambodia
1
Asia
1
Congo, Democratic Republic of
1
West and Central Africa
1
Turkmenistan
1
Denmark
1
Argentina
1
Russia
1
Egypt
1
Georgia
1
Mali
1
Libya
1
South Sudan
1
Iraq
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
274
Clinical Guidelines
93
Public Health
54
Women & Child Health
25
Capacity Building
20
Pharmacy & Technologies
5
Key Resources
2
Toolboxes
AMR
126
Mental Health
88
Pharmacy
65
HIV
42
NCDs
33
Caregiver
31
TB
30
Planetary Health
18
Disability
14
COVID-19
10
NTDs
10
Conflict
7
Refugee
5
Global Health Education
4
Rapid Response
3
Specific Hazards
1
Cholera
1
Ebola
1
Health Financing Toolbox
1
Polio
1
2014-2020, Draft March 2014
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e...
WHO Ghana 2022 annual report
recommended
“2022 was an eventful year for the WHO Country Office in Ghana,” says Dr Francis Kasolo, WHO Representative to Ghana.
In 2022, WHO Ghana collaborated with partners to deliver interventions in support of the Government of Ghana's health sector agenda to ensure healthy lives for all towards ach...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
WHO/Europe has launched a new guide, providing support to countries on how to apply behavioural and cultural insights (BCI) for health. It presents a simple step-wise approach, complemented by a rich collection of detailed considerations, tools and exercises. The guide is the first of its kind, spec...
Azraq refugee camp located in Zarqa governorate was established in April 2014. As of June 2023, the camp continues to hosts 40,600 Syrian refugees, with 61% of the population children, and 25% of all households female-headed (UNHCR, 2023).
The water supply system in Azraq has been operational sin...
Unpreparedness of health professionals to address non-communicable diseases (NCD) at peripheral health facilities is a critical health system challenge in Mozambique. To address this weakness and decentralize NCD care, training of the primary care workforce is needed. We describe our experience in t...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Hypertension is the number one health related risk factor in India, with the largest contribution to burden of disease and mortality. It contributes to an estimated 1.6 million deaths, due to ischemic heart disease and stroke, out of a total of about 10 million deaths annually in India. Fifty seven ...
The document provides the NICE Quality Standard for managing Type 2 diabetes in adults (QS209). It outlines evidence-based recommendations for preventing Type 2 diabetes, structured education, continuous glucose monitoring (CGM), medication such as SGLT2 inhibitors, and regular care processes to mon...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
In recent decades, India has witnessed a rapidly exploding epidemic of diabetes.
Indeed, India today has the second largest number of people with diabetes in the
world. The International Diabetes Federation (IDF) estimates that there are 72.9 million people with diabetes in India in 2017, which is...
